A multivalent RSV vaccine based on the modified vaccinia Ankara vector shows moderate protection against disease caused by RSV in older adults in a phase 3 clinical study

Related articles

1. Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospitalisation among adults aged 75-79 years in England

   This article has 20 authors:

   1. Rebecca Symes
   2. Heather J Whitaker
   3. Shazaad Ahmad
   4. David Arnold
   5. Suryabrata Banerjee
   6. Cariad M Evans
   7. Robin Gore
   8. Jennifer Hart
   9. Katy Heaney
   10. Onn Min Kon
   11. Anne Melhuish
   12. Munira Ortale Zogaib
   13. Emanuela Pelosi
   14. Najib Rahman
   15. Gerrit Woltmann
   16. Tricia McKeever
   17. Maria Zambon
   18. Conall H Watson
   19. Wei Shen Lim
   20. Jamie Lopez Bernal

2. Inactivated Zoonotic Influenza A(H5N8) Vaccine Induces Humoral and Cell-mediated Immune Responses Against Highly Pathogenic Avian Influenza Clade 2.3.4.4b A(H5N1) Viruses

   This article has 24 authors:

   1. Oona Liedes
   2. Arttu Reinholm
   3. Nina Ekström
   4. Anu Haveri
   5. Anna Solastie
   6. Saimi Vara
   7. Willemijn Rijnink
   8. Theo Bestebroer
   9. Mathilde Richard
   10. Rory de Vries
   11. Pinja Jalkanen
   12. Erika Lindh
   13. Niina Ikonen
   14. Alba Grifoni
   15. Alessandro Sette
   16. Terhi Laaksonen
   17. Riikka Holopainen
   18. Laura Kakkola
   19. Maija Lappalainen
   20. Ritva Syrjänen
   21. Pekka Kolehmainen
   22. Ilkka Julkunen
   23. Hanna Nohynek
   24. Merit Melin

3. Induction of systemic and mucosal immune response against Zika virus by vaccination with non-infectious chimeric VLPs

   This article has 5 authors:

   1. Luciana Agostina Fassola
   2. Lucía Lara Rupil
   3. Florencia Martínez
   4. Guillermo Albrieu-Llinás
   5. Marianela del Carmen Serradell